Corbus Pharmaceuticals Holdings (CRBP) FCF Margin (2015 - 2021)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly FCF Margin came in at 880.53% in Q3 2021, up 309972.0% year-on-year from N/an in Q3 2020, and up 106.86% quarter-over-quarter from 12835.99% in Q2 2021.
Corbus Pharmaceuticals Holdings (CRBP) FCF Margin (2015 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' FCF Margin history runs 7 years deep, the most recent figure standing at 880.53% for Q3 2021.
- On a quarterly basis, FCF Margin rose 309972.0% year-over-year to 880.53% in Q3 2021; TTM through Jun 2022 was 32631.18%, a 3036082.0% decrease from a year earlier, with the FY2021 full-year figure at 5470.98%, down 346757.0% from the prior year.
- FCF Margin rose to 880.53% in Q3 2021 per CRBP's latest filing, from 12835.99% in the prior quarter.
- Across five years, FCF Margin topped out at 880.53% in Q3 2021 and bottomed at 12835.99% in Q2 2021.
- The 5-year median for FCF Margin is 819.98% (2018), against an average of 2245.15%.
- Across the five-year window, FCF Margin jumped 606102 bps in 2019 and slumped 924062 bps in 2020, its largest moves.
- Year by year, FCF Margin stood at 795.15% in 2017, then slumped by 652 bps to 5977.53% in 2018, then surged by 101 bps to 83.49% in 2019, then slumped by 1365 bps to 1055.93% in 2020, then surged by 183 bps to 880.53% in 2021.
- Per Business Quant, the three latest CRBP FCF Margin figures stand at 880.53% (Q3 2021), 12835.99% (Q2 2021), and 3366.58% (Q1 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 880.53% |
| Jun 30, 2021 | -12,835.99% |
| Mar 31, 2021 | -3,366.58% |
| Dec 31, 2020 | -1,055.93% |
| Sep 30, 2020 | -2,219.20% |
| Jun 30, 2020 | -9,297.60% |
| Mar 31, 2020 | -1,592.73% |
| Dec 31, 2019 | 83.49% |
| Sep 30, 2019 | -705.89% |
| Jun 30, 2019 | -56.98% |
| Mar 31, 2019 | 543.51% |
| Dec 31, 2018 | -5,977.53% |
| Sep 30, 2018 | -820.69% |
| Jun 30, 2018 | -819.27% |
| Mar 31, 2018 | -221.70% |
| Sep 30, 2017 | -795.15% |
| Jun 30, 2017 | -1,639.01% |
| Mar 31, 2017 | -516.06% |
| Sep 30, 2016 | -387.56% |
| Jun 30, 2016 | -667.79% |